Dora Kovacs, Ph.D.
|
Associate Investigator Neurology, Mass General Research Institute |
|
Associate Professor of Neurology Harvard Medical School |
|
Research Staff Neurology, Massachusetts General Hospital |
| PhD University of Padova - Italy 1991 |
Research Interests
Research Narrative
My research focuses on the molecular events underlying neurodegeneration in Alzheimer’s disease (AD). Among other neuropathological features, cortical deposition of an insoluble material, called amyloid, occurs in both the aging and the AD-afflicted brain. I am interested in identifying the cellular pathways regulating the generation of the toxic beta-amyloid protein (Abeta), and the factors involved in the subsequent neurodegenerative process associated with this peptide.
We have shown that ACAT inhibitors have reduced generation of Abeta in cell-based models of AD and dramatically improved brain pathology in a transgenic mouse model of AD. We are currently synthesizing and testing novel ACAT inhibitors.
Research website
Publications
| dkovacs@mgh.harvard.edu |
|
CNY-Building #114 114 16th Street 3010 Charlestown, MA 02129 |